Evidence map›Paper›PMID 35207233›Full record

ArticleJournal of clinical medicine2022

Severe Asthma, Telemedicine, and Self-Administered Therapy: Listening First to the Patient.

Gabriella Guarnieri, Marco Caminati, Alessia Achille, Rachele Vaia, Fulvia Chieco Bianchi, Gianenrico Senna, Andrea Vianello

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Immunoglobulin replacement therapy in patients with immunodeficiencies: impact of infusion method on patient-reported outcomes.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gabriella GuarnieriRespiratory Pathophysiology Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Via Giustiniani 2, 35126 Padova, Italy.
Marco CaminatiDepartment of Medicine, University of Verona, Verona University Hospital, P.le L. Scuro 10, 37134 Verona, Italy.ORCID 0000-0001-7383-1487
Alessia AchilleRespiratory Pathophysiology Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Via Giustiniani 2, 35126 Padova, Italy.
Rachele VaiaAllergy Unit, Asthma Center, Verona University Hospital, P.le L. Scuro 10, 37134 Verona, Italy.
Fulvia Chieco BianchiRespiratory Pathophysiology Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Via Giustiniani 2, 35126 Padova, Italy.
Gianenrico SennaDepartment of Medicine, University of Verona, Verona University Hospital, P.le L. Scuro 10, 37134 Verona, Italy.
Andrea VianelloRespiratory Pathophysiology Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Via Giustiniani 2, 35126 Padova, Italy.ORCID 0000-0002-8790-6029

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe asthma patients are at an increased risk of major complications and they need to be monitored regularly. The COVID-19 pandemic has notably impacted on the health care resources. The telemedicine approach applied to the follow-up of asthmatic patients has been proven to be effective in monitoring their disease and their adherence to the therapy. The aim of our study was to investigate the satisfaction of severe asthma patients before the activation of a telemedicine management, as well as their current experience with self-administration of injection therapy. An

Indexed as

adherencebiologicshome-administrationpatient empowermentpatient preferences

Identifiers

PMID35207233
PMCPMC8880352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.